Markets:

Overview

News

Currencies

International

Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

45.91 +0.48 (+1.06%)

Streaming Delayed Price Updated: 12:28 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

Cathie Wood Loads Up More On Alibaba Rivals Pinduoduo, JD — Also Adds Skillz ↗

May 04, 2021

Cathie Wood-led Ark Investment Management on Monday bought more shares of Pinduoduo Inc (NASDAQ: PDD) and JD.com Inc (NASDAQ: JD) — rivals to Alibaba Group Holding (...

Via Benzinga

Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies

May 03, 2021

Via FinancialNewsMedia

Topics Death

Biopharma Stocks Stall After Earnings, Lag Over 52 Weeks ↗

May 01, 2021

It is hard to forecast with the current choppy setting in the biopharma sector, but assuming that the COVID-19 vaccinations are on track in the U.S., financial results should improve for most large-cap...

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Another Heavy News Day ↗

April 29, 2021

For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.

Via Talk Markets

Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer ↗

April 29, 2021

The FDA’s Oncologic Drugs Advisory Committee voted 5-3 in favor of keeping Merck & Co’s (NYSE: MRK) Keytruda (pembrolizumab) accelerated approval...

Via Benzinga

Atea Pharma Stock Is Trading Higher As AT-527 Study In COVID-19 Moves Forward With Dosing ↗

April 29, 2021

Atea Pharmaceuticals Inc (NASDAQ: AVIR) has dosed the first patient in the Phase 3 MORNINGSKY trial evaluating AT-527 in mild or moderate COVID-19 patients in...

Via Benzinga

A Heavy News Day And Crypto ↗

April 28, 2021

Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.

Via Talk Markets

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for Previously Untreated Metastatic Bladder Cancer

April 28, 2021

From Genentech

Via Business Wire

FDA Oncology Adcomm Votes To Keep Conditional Approval For Roche's Tecentriq In Place For Now ↗

April 28, 2021

The FDA kicked off a three-day meet to reexamine the accelerated approvals of immuno-oncology drugs with confirmatory trials that have not met their primary endpoint(s) and have...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

April 27, 2021

From Genentech

Via Business Wire

Tuesday Market Report ↗

April 27, 2021

Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.

Via Talk Markets

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Disruptor Alert: These 2 Companies Are Changing Cancer Care ↗

April 24, 2021

Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers.

Via The Motley Fool

Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion ↗

April 23, 2021

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending approval of Roche Holdings AG’s (...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Earth Day ↗

April 22, 2021

Once again the exchanges are unsure if they want to go up or down.

Via Talk Markets

Cathie Wood Loads Up Heavily On Debutant Uipath, Trims Tesla ↗

April 22, 2021

Cathie Wood-led Ark Investment Management on Wednesday snapped up millions of shares of the New York-based software automation company UiPath Inc (NYSE: PATH) on the day that it...

Via Benzinga

Gold Is Back ↗

April 21, 2021

Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs.

Via Talk Markets

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

Roche Backs 2021 Outlook Despite Lackluster Q1 Performance In Pharmaceuticals Division ↗

April 21, 2021

Roche Holdings AG (OCTMKTS: RHHBY) posted Q1 sales of CHF 14.9 billion, up 3% Y/Y on a constant currency basis and down 1% on a reported basis. Sales in the...

Via Benzinga

Cathie Wood Loads Up On DraftKings, Coinbase, Palantir, Sells Nvidia, Square ↗

April 21, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up another 236,348 shares of cryptocurrency exchange Coinbase Global...

Via Benzinga

Cathie Wood Buys Peloton, Coinbase Dips, Cuts Nvidia Stake ↗

April 20, 2021

Cathie Wood-led Ark Investment Management on Monday snapped up shares of the exercise bike maker Peloton Interactive Inc (NASDAQ:

Via Benzinga

Currency Manipulation ↗

April 16, 2021

London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53.

Via Talk Markets

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

April 16, 2021

From Genentech

Via Business Wire

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗

April 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)

April 15, 2021

From Genentech

Via Business Wire

Electric Cancer Cure ↗

April 13, 2021

Most US stocks were down on fear of inflation and financial risks but then rose after lunch.

Via Talk Markets

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.